Search results
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports. Barclays‘s ...
Leukemia Therapeutics Market Expected to Grow at USD 13491.42 Million by 2030: SNS Insider
Digital Journal· 3 days agoThe global leukemia therapeutics market has witnessed significant growth in recent years, driven by...
Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?
Zacks· 5 days agoSmart Beta ETF report for DGRW